EBQ:Lactate clearance vs central venous oxygen saturation

From WikEM
Jump to: navigation, search
incomplete Journal Club Article
Jones AE.. "Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial". JAMA. 2010. 303(8):739-746.
PubMed Full text PDF

Clinical Question

Is lactate clearance as good as SVO2 as a measure of oxygen delivery to tissues in patients presenting with severe sepsis and septic shock?


For patients with septic shock who were treated by normalizing CVP and MAP; attempt to normalize lactate clearance as opposed to normalize SVO2 showed no significant difference in in-hospital mortality.

Major Points

Inclusion Criteria

  • >17 years old AND
  • confirmed or presumed infection meeting criteria for severe sepsis or septic shock:
    • 2 or more SIRS criteria AND
    • SBP <90 after 20 mL/kg bolus or blood lactate at least 36 mg/dL

Exclusion Criteria

  • Pregnancy
  • Primary diagnosis other than sepsis
  • Likely surgery required within 6 hours of diagnosis
  • Contraindication to chest or neck CVC
  • Cardiopulmonary resuscitation
  • Transfer from an institution with sepsis protocol already underway
  • Advance directive restricting study protocol


  • Randomized into 1 of 2 resuscitation groups
  • CVP was managed first in both groups to achieve a CVP of at least 8
    • Isotonic boluses given
  • SBP was managed second to maintain a MAP of at least 65
    • Fluid resuscitation followed by vasopressors (dopamine and norepi)
  • The groups differed in the third physiologic parameter that was targeted: SVO2 vs. lactate clearance
    • SVO2 of 70%
    • lactate clearance of 10%
    • If hematocrit <30 and either target not achieved, PRBC transfusion to achieve hematocrit of at least 30
    • If hematocrit was at least 30 and either target not achieved, then dopamine titrated to achieve effect


*Intention to treat analysis

Primary Outcomes

  • Absolute in-hospital mortality rate
    • SVO2: 23%
    • Lactate: 17%
    • Did not reach -10% threshold

Secondary Outcomes

  • ICU length of stay
    • SVO2: 8.46%
    • Lactate: 7.39%
    • p-value = 0.75
  • Hospital length of stay
    • SVO2: 10.89%
    • Lactate: 11.68%
    • p-value = 0.60
  • Ventilator-free days
    • SVO2: 10.39%
    • Lactate: 11.09%
    • p-value = 0.67
  • New onset of multiple organ failure
    • SVO2: 25%
    • Lactate: 22%
    • p-value = 0.68

Subgroup analysis